Population
Adult SHRSP (stroke-prone spontaneously hypertensive rats)
Comparison
Angiotensin II for 4 hours, with or without… vs Vehicle (0.9% NaCl IV)
Design
Preclinical
Follow-up
4 hours
Authors
Loading...
Supports AT2-bradykinin-NO cGMP pathway in hypertensive rat models; leaves open human therapeutic relevance.
Angiotensin II increases aortic cGMP in stroke-prone spontaneously hypertensive rats via an AT2 receptor-mediated mechanism dependent on bradykinin and nitric oxide.
Gohlke et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: